GlassScriptPhysician profile
Juliana Lopez Klein
NPI 1851657472
$5,077.98
in general payments reported to CMS, 2019-2025
35 companies · $405 in 2025
The $405 reported for 2025 was more than what 75% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,393 · 2020: $34.61 · 2021: $163 · 2022: $253 · 2023: $428 · 2024: $402 · 2025: $405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,234.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,083.61 | 2019-2023 | Da Vinci Surgical System |
| Organon LLC | $228.74 | 2021-2025 | Nexplanon |
| Abbvie INC. | $201.39 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $168.02 | 2023-2025 | Myfembree |
| Astellas Pharma US INC | $153.16 | 2024-2025 | Veozah |
| Hologic Sales and Service, LLC | $136.01 | 2019-2023 | Coolseal Generator, Novasure, Acessa Provu System |
| Exeltis, USA INC. | $110.54 | 2021-2025 | Slynd |
| Mayne Pharma Commercial LLC | $90.33 | 2022-2025 | |
| Pfizer INC. | $86.81 | 2022-2024 | |
| Sage Therapeutics, LLC | $84.14 | 2024-2025 | Zurzuvae |
| Smith+Nephew, INC. | $69.12 | 2019 | |
| Daiichi Sankyo INC. | $61.02 | 2019-2024 | Injectafer |
| Applied Medical Resources Corporation | $60.42 | 2021 | |
| Innovation Technologies INC | $48.21 | 2023 | Irrisept |
| Millicent US INC | $47.07 | 2019-2025 | Femlyv |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $46.42 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $45.38 | 2019-2020 | |
| Therapeuticsmd, INC. | $40.56 | 2019-2021 | |
| Myovant Sciences INC. | $32.30 | 2022 | |
| Boston Scientific Corporation | $26.74 | 2022 | |
| Lupin INC. | $25.14 | 2019 | |
| Dexcom, INC. | $24.55 | 2025 | Dexcom G6 Transmitter |
| Medtronic, INC. | $23.67 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $23.51 | 2025 | |
| Allergan, INC. | $22.73 | 2020 | |
| Baxter Healthcare | $19.72 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.28 | 2019 | |
| Supernus Pharmaceuticals, INC. | $15.71 | 2025 | Qelbree |
| Duchesnay USA Incorporated | $14.80 | 2019 | |
| Mission Pharmacal Company | $14.36 | 2019 | |
| Novo Nordisk INC | $14.35 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $13.49 | 2019 | |
| Minerva Surgical, INC | $11.98 | 2022 | |
| Medicem INC. | $11.62 | 2021 | |
| Bolder Surgical LLC | $4.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juliana Lopez Klein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.